428 related articles for article (PubMed ID: 25582881)
1. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study.
Bartoloni E; Baldini C; Schillaci G; Quartuccio L; Priori R; Carubbi F; Bini V; Alunno A; Bombardieri S; De Vita S; Valesini G; Giacomelli R; Gerli R
J Intern Med; 2015 Aug; 278(2):185-92. PubMed ID: 25582881
[TBL] [Abstract][Full Text] [Related]
2. Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjögren's syndrome: a novel pathogenetic scenario?
Bartoloni E; Baldini C; Ferro F; Alunno A; Carubbi F; Cafaro G; Bombardieri S; Gerli R; Grossi E
Clin Exp Rheumatol; 2019; 37 Suppl 118(3):133-139. PubMed ID: 31464678
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease in Primary Sjögren's Syndrome.
Berardicurti O; Ruscitti P; Cipriani P; Ciccia F; Liakouli V; Guggino G; Carubbi F; Di Benedetto P; Triolo G; Giacomelli R
Rev Recent Clin Trials; 2018; 13(3):164-169. PubMed ID: 29542415
[TBL] [Abstract][Full Text] [Related]
5. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
Yang Y; Li Z; Wang L; Zhang F
Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients.
Pérez-De-Lis M; Akasbi M; Sisó A; Diez-Cascon P; Brito-Zerón P; Diaz-Lagares C; Ortiz J; Perez-Alvarez R; Ramos-Casals M; Coca A
Lupus; 2010 Jul; 19(8):941-8. PubMed ID: 20581017
[TBL] [Abstract][Full Text] [Related]
7. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
8. Association between primary Sjögren's syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis.
Yong WC; Sanguankeo A; Upala S
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):190-197. PubMed ID: 29600936
[TBL] [Abstract][Full Text] [Related]
9. The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren's Syndrome: Is Uric Acid the Missing Link?
Alunno A; Carubbi F; Mariani FM; Martini C; Campanozzi E; Ferri C
Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049403
[TBL] [Abstract][Full Text] [Related]
10. Risk of Cardiovascular Involvement in Patients with Primary Sjögren's Syndrome: a large-scale cross-sectional cohort study.
Cai X; Luo J; Wei T; Qin W; Wang X; Li X
Acta Reumatol Port; 2019; 44(1):71-77. PubMed ID: 31249278
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome.
Bartoloni E; Alunno A; Valentini V; Valentini E; La Paglia GMC; Leone MC; Cafaro G; Marcucci E; Bonifacio AF; Luccioli F; Gerli R
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):113-120. PubMed ID: 29998823
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I; Fernández Castro M; Andreu JL; Sanchez-Piedra C; Martínez-Taboada V; Olivé A; López-Longo J; Rosas J; Galindo M; Calvo-Alén J; Fernández-Nebro A; Alonso F; Rodríguez-Lozano B; Alberto García Vadillo J; Menor R; Narváez FJ; Erausquin C; García-Aparicio Á; Tomero E; Manrique-Arija S; Horcada L; Uriarte E; Gil S; Blanco R; López-González R; Boteanu A; Freire M; Galisteo C; Rodríguez-Gómez M; Díez-Álvarez E; Pego-Reigosa JM;
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):38-45. PubMed ID: 27564390
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni E; Carubbi F; Gregoraci G; Gandolfo S; Salvin S; Luciano N; Minniti A; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
Scand J Rheumatol; 2015; 44(1):36-41. PubMed ID: 25268749
[TBL] [Abstract][Full Text] [Related]
14. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
15. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis.
Zehrfeld N; Abelmann M; Benz S; Zippel CL; Beider S; Kramer E; Seeliger T; Sogkas G; Gödecke V; Ahrenstorf G; Armbruster FP; Skripuletz T; Witte T; Derda AA; Sonnenschein K; Ernst D
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38663882
[TBL] [Abstract][Full Text] [Related]
16. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics.
Kvarnström M; Ottosson V; Nordmark B; Wahren-Herlenius M
Scand J Rheumatol; 2015; 44(2):135-42. PubMed ID: 25222653
[TBL] [Abstract][Full Text] [Related]
17. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study.
Harboe E; Tjensvoll AB; Maroni S; Gøransson LG; Greve OJ; Beyer MK; Herigstad A; Kvaløy JT; Omdal R
Ann Rheum Dis; 2009 Oct; 68(10):1541-6. PubMed ID: 18930990
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
20. Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations.
Gravani F; Papadaki I; Antypa E; Nezos A; Masselou K; Ioakeimidis D; Koutsilieris M; Moutsopoulos HM; Mavragani CP
Arthritis Res Ther; 2015 Apr; 17(1):99. PubMed ID: 25886059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
